Skip to main content

Table 5 Group 2 Patients not achieving SVR

From: Efficacy and tolerability of sofosbuvir and daclatasvir for treatment of hepatitis C genotype 1 & 3 in patients undergoing hemodialysis- a prospective interventional clinical trial

Gender

Cirrhosis

Previous Treatment

Baseline PCR (log 10 IU/ml)

ETR

SVR12

PCR (log 10 IU/ml)

Genotype

Male

No

Yes

5.86

Not Detected

5.51

1

Female

No

No

5.60

Not Detected

4.11

1

Male

No

Yes

5.86

Not Detected

5.50

1